Solanine Represses Gastric Cancer Growth by Mediating Autophagy Through AAMDC/MYC/ATF4/Sesn2 Signaling Pathway
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s389764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Xiaolong Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Solanine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China.
- Department of Oncology, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China.
- Department of Oncology, the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China.
ORCID-Profile: Sijia Zhang, Yuhao Teng
Zitieren
APA
Tang, X., Guo, Y., Zhang, S., Wang, X., Teng, Y., Jin, Q., Jin, Q., Shen, W., & Wang, R. (2023). Solanine Represses Gastric Cancer Growth by Mediating Autophagy Through AAMDC/MYC/ATF4/Sesn2 Signaling Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s389764
Vancouver
Tang X, Guo Y, Zhang S, Wang X, Teng Y, Jin Q, et al. Solanine Represses Gastric Cancer Growth by Mediating Autophagy Through AAMDC/MYC/ATF4/Sesn2 Signaling Pathway. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s389764
BibTeX
@article{Tang2023,
author = {Tang, Xiaolong and Guo, YingYing and Zhang, Sijia and Wang, Xin and Teng, Yuhao and Jin, Qingjiang and Jin, Qinglei and Shen, Wei and Wang, Ruiping},
title = {Solanine Represses Gastric Cancer Growth by Mediating Autophagy Through AAMDC/MYC/ATF4/Sesn2 Signaling Pathway},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s389764}
}
EUVIMED